The North America ELISpot and FluoroSpot assay market is expanding steadily due to rising demand for advanced immune monitoring technologies across clinical research and biotechnology applications. Growing investments in immunotherapy, vaccine development, and translational research, along with expanding laboratory infrastructure, are driving market growth. The region's advanced healthcare and...